Arlen Stawasz is a Regional Resilience Leader for Gensler in the EU and has focused his career on ESG resilience planning for zero net energy, carbon, and water-focused architectural design. He has expertise in flood resilient architecture, climate adaptation / social equity strategy, and emergency disaster response systems – working with many communities on multiple projects at various scales across the globe. In addition, Arlen has conducted extensive research in many countries to learn from the most advanced water focused societies and their unique conditions of living with water and extreme heat. Arlen serves as an adjunct faculty member of the Boston Architectural College with a focus on teaching advanced resilient design and climate adaptation architectural studios.
Archives: Speakers
Aron Bohmann
Aron is an expert on urban design, smart cities and housing. At Buro Happold he leads the Smart Cities offer in Europe and works on urban developments and master planning projects, as well as on the implementation of integrated infrastructures.
He advises public and private sector clients on the use of smart city applications in the best interest of the inhabitants. He understands the digital transition and the use of smart technologies as cross-sectional topics that integrate technical aspects like mobility and energy as well as experience-driven elements that result in behaviour and experience.
Before joining the company, Aron directed the German Mobility Award, which is awarded to the most progressive, data-driven mobility solutions in Germany. At the same time, he taught urban planning classes at HafenCity University in Hamburg. Prior, he was one of three curators on Conflicts of an Urban Age, an exhibition for the Venice Biennale, about current urban challenges.
Aron also worked for various clients as researcher, on urban design competitions and as technical expert. He is well versed on organising and conducting public and stakeholder consultations and other participatory processes.
Aron studied Urban and Regional Planning in Vienna and Istanbul before completing a MSc in Urban Design in Hamburg and a MSc in City Design and Social Science in London.
Michael Swiszczowski
Anne F. Lewis
Ms. Lewis is an experienced and versatile professional with over 25 years in the clinical research industry across a variety of therapeutic areas using a range of methodologies and strategies. Her experience includes the design and implementation of phase 3 and 4 studies as well as large-scale global safety and effectiveness registries, clinical trial simulations and digital app experience workshops. She has led numerous qualitative research projects involving patients, caregivers and healthcare professionals. In addition, Ms. Lewis has spearheaded the development of educational materials and communications for patients and physicians, as well as oversight of several large-scale longitudinal survey-based projects. In addition, she has created content for and scripted multiple Investigator Meetings as well as Study Team launch meetings. She has held positions within the healthcare sector, CROs and pharmaceutical industry, as Project Director, Director of Late Phase Research, Director of Health Economics and Outcomes Research, Senior Project Manager, and Senior Clinical Administrator for a research foundation.
Joost Samyn
Joost Samyn, Belgian, joined Celli Group in April 2021 after 30 years’ experience within the draught beer business. Since January 2022 he is the Regional Business Director WeMeA and in charge of the different branches in Germany, France, and Spain. Together with a great team he’s trying to grow the draught drinks market for beer and also for non-alcoholic drinks and water in the area.
JAMES L. SHERLEY, M.D., PH.D.
James L. Sherley, M.D., Ph.D. is the founder, President, and CEO of Massachusetts stem cell biotechnology company Asymmetrex, LLC. Asymmetrex develops and markets technologies for advancing stem cell medicine, including the first method achieving specific and accurate certification of the dosage of therapeutic tissue stem cells, called kinetic stem cell (KSC) counting. Asymmetrex’s kinetic stem cell counting platforms are also used to optimize manufacturing of therapeutic stem cells and for evaluations of drug effects on tissue stem cells. Dr. Sherley is a graduate of Harvard College, with a B.A. degree in biology, and the Johns Hopkins University School of Medicine, earning joint M.D. and Ph.D. degrees. Prior to founding Asymmetrex, he held academic research appointments at the Fox Chase Cancer Center, Massachusetts Institute of Technology, and Boston Biomedical Research Institute. Dr. Sherley’s professional awards include Pew Biomedical Research Scholar, Ellison Medical Foundation Senior Scholar in Aging Research, and NIH Director’s Pioneer Award.
JILL DOLGIN
Luca Pollani
Maria Milas
Maria joined the clinical trials field as a Clinical Trial Assistant for one of the top 10 CROs supporting Clinical Research Associates (CRA) with the management of the trial documentation, focusing on Oncology phases II and III trials. After a Master in Clinical Trial Monitoring and some experience, Maria changed to a CRA role monitoring trials phases I-IV in different therapeutical areas: oncology, respiratory, rare diseases, hematology, etc. Five years later, Maria joined Teckro to help bring technological innovation to clinical sites.